Probability Concepts in Quality Risk Management

References

1. 1.↵
   1. Mlodinow L.

   The Drunkard's Walk: How Randomness Rules Our Lives; Vintage Books: New York, 2008.

   Google Scholar
2. 2.↵
   1. Singpurwalla N. D.,
   2. Wilson A. G.

   Probability, chance and the probability of chance. IIE Transactions 2009, 41 (1),12–22.

   OpenUrlGoogle Scholar
3. 3.↵
   1. Bernstein P.

   Against the Gods. The Remarkable Story of Risk; John Wiley & Sons: New York, 1996.

   Google Scholar
4. 4.↵
   1. Visschers V. H.,
   2. Meertens R. M.,
   3. Passchier W. W.,
   4. de Vries N. N.

   Probability information in risk communication: a review of the research literature. Risk Anal. 2009, 29 (2),267–287.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
5. 5.↵
   1. Gigerenzer G.,
   2. Hertwig R.,
   3. van den Broek E.,
   4. Fasolo B.,
   5. Katsikopoulos K. V.

   “A 30% chance of rain tomorrow”: How does the public understand probabilistic weather forecasts? Risk Anal. 2005, 25 (3),623–629.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
6. 6.↵
   1. Pearl J.

   Causality: Models, Reasoning and Inference; Cambridge University Press: Cambridge, UK, 2000.

   Google Scholar
7. 7.↵
   1. Anonymous

   . “Common Cause and Special Cause”; wikipedia.org. http://en.wikipedia.org/wiki/Common_cause_and_special_cause (accessed March 21, 2011).

   Google Scholar
8. 8.↵
   1. Ayyub B. M.

   Risk Analysis in Engineering and Economics; Chapman and Hall/CRC: Boca Raton, FL, 2003.

   Google Scholar
9. 9.↵
   1. Kaplan S.,
   2. Garrick B. J.

   On the quantitative definition of risk. Risk Anal. 1981, 1 (1),11–27.

   OpenUrlCrossRefGoogle Scholar
10. 10.↵
    Quality Risk Management Q9, ICH Harmonised Tripartite Guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf (accessed April 19, 2011).

    Google Scholar
11. 11.↵
    Food and Drug Administration (FDA). Guidance for Industry Q9 Quality Risk Management. Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), 2006.

    Google Scholar
12. 12.↵
    International Standards Organization (ISO). Application of Risk Management to Medical Devices,International Standard ISO14971:2000.

    Google Scholar
13. 13.↵
    ISO. Risk Management—Principles and Guidelines. International Standard ISO 31000:2009(E).

    Google Scholar
14. 14.↵
    1. Aven T.,
    2. Renn O.

    On risk defined as an event where the outcome is uncertain. J. Risk Res. 2009, 12 (1),1–11.

    OpenUrlCrossRefWeb of ScienceGoogle Scholar
15. 15.↵
    1. Hubbard D. G.

    How to Measure Anything; Wiley: New York, 2007.

    Google Scholar
16. 16.↵
    1. Savage S. L.

    The Flaw of Averages: Why We Underestimate Risk in the Face of Uncertainty; John Wiley & Sons: Hoboken, NJ, 2009.

    Google Scholar
17. 17.↵
    1. Keeney R.

    Making better decision makers. Decision Anal. 2004, 1 (4),193–204.

    OpenUrlCrossRefGoogle Scholar
18. 18.↵
    1. Kahneman D.,
    2. Slovic P.,
    3. Tversky A.

    Judgment under Uncertainty: Heuristics and Biases; Cambridge University Press: Cambridge, UK, 1982.

    Google Scholar
19. 19.↵
    1. Mauboussin M. J.

    Think Twice: Harnessing the Power of Counterintuition; Harvard Business Press: Boston, 2009.

    Google Scholar
20. 20.↵
    1. Ariely D.

    Predictably Irrational: The Hidden Forces that Shape Our Decisions; Harper-Collins: New York, 2008.

    Google Scholar
21. 21.↵
    1. Hubbard D. L.

    The Failure of Risk Management: Why It's Broken and How to Fix It; John Wiley & Sons: Hoboken, NJ, 2009.

    Google Scholar
22. 22.↵
    1. Jaffe J.,
    2. Stavins R. N.

    On the value of formal assessment of uncertainty in regulatory analysis. Regulation & Governance 2007, 1 (2),154–171.

    OpenUrlGoogle Scholar
23. 23.↵
    1. Morgan M. G.,
    2. Henrion M.

    Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis; Cambridge University Press: Cambridge, UK, 1990.

    Google Scholar
24. 24.↵
    1. Keeney R. L.

    Value-Focused Thinking; Cambridge University Press: Cambridge, UK, 1992.

    Google Scholar
25. 25.↵
    1. Thornton A. C.

    Variation Risk Management. John Wiley & Sons: Hoboken, NJ, 2004.

    Google Scholar
26. 26.↵
    1. Claycamp H. G.

    Risk, uncertainty, and process analytical technology. J. Process Anal. Technol. 2006, 3 (2),8–12.

    OpenUrlGoogle Scholar
27. 27.↵
    ICH. Pharmaceutical Development Q8(R2), ICH Harmonised Tripartite Guideline, Current Step 4 version, August 2009. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed July 20, 2011).

    Google Scholar
28. 28.↵
    ICH. Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities), Draft Consensus Guideline, Current Step 2 version, May 2011. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed July 20, 2011).

    Google Scholar
29. 29.↵
    1. Harry M.,
    2. Schroeder R.

    Six Sigma: The Breakthrough Management Strategy Revolutionizing the World's Top Corporations; Currency Press: New York, 2000.

    Google Scholar
30. 30.↵
    1. Vose D.

    Risk Analysis: A Quantitative Guide, 2nd ed.; John Wiley & Sons: Chichester, UK, 2000.

    Google Scholar
31. 31.↵
    1. Claycamp H. G.

    . Perspective on quality risk management of pharmaceutical quality. Drug Information J. 2007, 41 (3),353–367.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
32. 32.↵
    1. Haimes Y. Y.

    Risk Modeling, Assessment, and Management; John Wiley & Sons: New York, 2004.

    Google Scholar
33. 33.↵
    1. Linkov I.,
    2. Satterstrom F. K.,
    3. Kiker G.,
    4. Batchelor C.,
    5. Bridges T.,
    6. Ferguson E.

    Comparative risk assessment to multi-criteria decision analysis and adaptive management: recent developments and applications. Environ. Int. 2006, 32 (8),1072–1093.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
34. 34.↵
    1. Haimes Y. Y.,
    2. Kaplan S.,
    3. Lambert J. H.

    Risk filtering, ranking, and management framework using hierarchical holographic modeling. Risk Anal. 2002, 22 (2),383–397.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
35. 35.↵
    1. Morgan G. M.,
    2. Florig H. K.,
    3. DeKay M. L.,
    4. Fischbeck P.

    Categorizing risks for risk ranking. Risk Anal. 2000, 20 (1),49–58.

    OpenUrlCrossRefPubMedGoogle Scholar
36. 36.↵
    1. O'Hagan A.,
    2. Buck C. E.,
    3. Daneshkhah A.,
    4. Eiser J. R.,
    5. Garthwaite P. H.,
    6. Jenkinson D. J.,
    7. Oakley J. E.,
    8. Rakow T.

    Uncertain Judgments: Eliciting Experts' Probabilities; John Wiley & Sons: West Sussex, UK, 2006.

    Google Scholar
37. 37.↵
    1. Cox L. A. Jr..

    What's wrong with risk matrices? Risk Anal. 2008, 28 (2),497–512.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
38. 38.↵
    1. Taleb N. N.

    The Black Swan: The Impact of the Highly Improbable. Random House: New York, 2007.

    Google Scholar
39. 39.↵
    1. Ishikawa K.

    What Is Total Quality Control? The Japanese Way, Lui, D. J., trans.; Prentice-Hall: Englewood Cliffs, NJ, 1985.

    Google Scholar
40. 40.↵
    U.S. Department of Energy. DOE Guideline. Root Cause Analysis Guidance Document, Office of Nuclear Energy, Office of Nuclear Energy Safety Policy and Standards: Washington, DC, 1992.

    Google Scholar
41. 41.↵
    1. Stamatis D. H.

    Failure Mode and Effect Analysis: FMEA from Theory to Execution, 2nd ed.; ASQ Quality Press: Milwaukee, WI, 2003.

    Google Scholar
42. 42.↵
    1. Rönninger S.,
    2. Holmes M.

    A risk-based approach to scheduling audits. PDA J. Pharm. Sci. Technol. 2009, 63 (6),575–588.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
43. 43.↵
    1. Tran N. L.,
    2. Hasselbalch B.,
    3. Morgan K.,
    4. Claycamp G.

    Elicitation of expert knowledge about risks associated with pharmaceutical manufacturing processes. Pharmaceutical Engineering 2005, 25 (4),24–38.

    OpenUrlGoogle Scholar
44. 44.↵
    1. Ayyub B. M.

    Elicitation of Expert Opinions for Uncertainty and Risks; CRC Press: Boca Raton, FL, 2001.

    Google Scholar
45. 45.↵
    1. Morgan M. G.,
    2. Fischhoff B.,
    3. Bostrom A.,
    4. Atman C. J.

    Risk Communication: A Mental Models Approach; Cambridge University Press: Cambridge, UK, 2002.

    Google Scholar
46. 46.↵
    1. Brafman O.

    Sway: The Irresistible Pull of Irrational Behavior; Doubleday: New York, 2008.

    Google Scholar
47. 47.↵
    1. Dieckmann N. F.,
    2. Slovic P.,
    3. Peters E. M.

    The use of narrative evidence and explicit likelihood by decisionmakers varying in numeracy. Risk Anal. 2009, 29 (10),1473–1488.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
48. 48.↵
    1. Bond S. D.,
    2. Carlson K. A.,
    3. Keeney R. L.

    Improving the generation of decision objectives. Decision Anal. 2010, 7 (3),238–255.

    OpenUrlCrossRefGoogle Scholar